Current advances and challenges in the development of Acinetobacter vaccines

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2015-07-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/21645515.2015.1052354PMID 26158773PMCID PMC4635877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outer membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristics.

  2015cited by this paper
• Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble.

  2015influential reference
• Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.

  2015cited by this paper
• Glycoconjugate vaccines: an update

  2015cited by this paper
• Clinical implications of glycoproteomics for Acinetobacter baumannii

  2015cited by this paper
• Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology

  2015cited by this paper
• AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments

  2014cited by this paper
• In Silico Analysis of Acinetobacter baumannii Phospholipase D as a Subunit Vaccine Candidate

  2014cited by this paper
• Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models

  2014cited by this paper
• Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii.

  2014cited by this paper
• Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach

  2014influential reference
• Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection

  2014cited by this paper
• Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia.

  2014cited by this paper
• Vaccines against Clostridium difficile

  2014cited by this paper
• First steps towards a vaccine against Acinetobacter baumannii.

  2014cited by this paper
• Where does a Staphylococcus aureus vaccine stand?

  2014cited by this paper
• Vaccines for Acinetobacter baumannii: thinking "out of the box".

  2014influential reference
• Diversity in the Major Polysaccharide Antigen of Acinetobacter Baumannii Assessed by DNA Sequencing, and Development of a Molecular Serotyping Scheme

  2013cited by this paper
• A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii.

  2013cited by this paper
• A Mouse Model of Acinetobacter baumannii-Associated Pneumonia Using a Clinically Isolated Hypervirulent Strain

  2013cited by this paper
• Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii

  2013cited by this paper
• The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization

  2013influential reference
• Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.

  2013cited by this paper
• The Nod1, Nod2, and Rip2 Axis Contributes to Host Immune Defense against Intracellular Acinetobacter baumannii Infection

  2013cited by this paper
• Evaluation of the Trimeric Autotransporter Ata as a Vaccine Candidate against Acinetobacter baumannii Infections

  2012influential reference
• Role of Macrophages in Early Host Resistance to Respiratory Acinetobacter baumannii Infection

  2012cited by this paper
• Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection

  2012influential reference
• Poly-N-Acetyl-β-(1-6)-Glucosamine Is a Target for Protective Immunity against Acinetobacter baumannii Infections

  2011influential reference
• Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.

  2011cited by this paper
• Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap).

  2011cited by this paper
• Innate Immune Responses to Systemic Acinetobacter baumannii Infection in Mice: Neutrophils, but Not Interleukin-17, Mediate Host Resistance

  2011cited by this paper
• Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii

  2010cited by this paper
• The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor

  2010cited by this paper
• Insights into Acinetobacter War-Wound Infections, Biofilms, and Control

  2010influential reference
• Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.

  2010cited by this paper
• Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins.

  2009cited by this paper
• Synthetic β-(1→6)-Linked N-Acetylated and Nonacetylated Oligoglucosamines Used To Produce Conjugate Vaccines for Bacterial Pathogens

  2009influential reference
• Acinetobacter: an old friend, but a new enemy.

  2009cited by this paper
• Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii.

  2009cited by this paper
• High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils.

  2009cited by this paper
• Acinetobacter baumannii: Emergence of a Successful Pathogen

  2008influential reference
• A case for immunization against nosocomial infections

  2008cited by this paper
• Anti-tumor activity of Acinetobacter baumannii outer membrane protein A on dendritic cell-based immunotherapy against murine melanoma

  2008cited by this paper
• Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology

  2008cited by this paper
• Protection against Nasopharyngeal Colonization by Streptococcus pneumoniae Is Mediated by Antigen-Specific CD4+ T Cells

  2008cited by this paper
• The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications.

  2007influential reference
• Acinetobacter pneumonia: a review.

  2007cited by this paper
• Neutrophils Play an Important Role in Host Resistance to Respiratory Infection with Acinetobacter baumannii in Mice

  2007cited by this paper
• Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal

  2001cited by this paper
• Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production

  2000cited by this paper
• Serotyping of clinical isolates of Acinetobacter baumannii and genospecies 13 capable of growth at 44 degrees C: detection of four new serovars.

  1998cited by this paper
• Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem

  1997cited by this paper

• Design a multi-epitope vaccine candidate against Acinetobacter baumannii using advanced computational methods

  2025cites this paper
• Development of a multi-epitope vaccine against Acinetobacter baumannii: A comprehensive approach to combating antimicrobial resistance

  2025cites this paper
• Assessment of the current state of pharmaceutical development of anti-staphylococcal prophylactic drugs

  2024cites this paper
• Acinetobacter spp. in neonatal sepsis: an urgent global threat

  2024cites this paper
• Antibodies anti-rFilF protein has anti-biofilm activity against carbapenem-resistant Acinetobacter baumannii.

  2024cites this paper
• Development of acute Pseudomonas aeruginosa and Acinetobacter baumannii lung mono-challenge models in mice using oropharyngeal aspiration

  2024cites this paper
• An In silico Study on B-cell Epitope Mapping of Acinetobacter baumannii Outer Membrane Protein K.

  2024cites this paper
• Vaccination strategies to combat nosocomial infections

  2023cites this paper
• The Prevalence of Multidrug-Resistant Acinetobacter baumannii and Its Vaccination Status among Healthcare Providers

  2023cites this paper
• Two peptides derivate from Acinetobacter baumannii outer membrane protein K as vaccine candidates: a comprehensive in silico study

  2023cites this paper
• Acinetobacter baumannii subunit vaccines: recent progress and challenges

  2023cites this paper
• Protective Capacity of Monoclonal Antibodies against Acinetobacter baumannii K9 Capsular Polysaccharide

  2023cites this paper
• The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus

  2022cites this paper
• A novel pentavalent vaccine candidate completely protects against Acinetobacter baumannii in a mouse model of peritonitis

  2022cites this paper
• Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model.

  2022cites this paper
• Nanobionics: From plant empowering to the infectious disease treatment.

  2022cites this paper
• Immunoprotective characterization of egg yolk immunoglobulin raised to loop 3 of outer membrane protein 34 (Omp34) in a murine model against Acinetobacter baumannii.

  2022cites this paper
• Evaluation the reactivity of a peptide-based monoclonal antibody derived from OmpA with drug resistant pulsotypes of Acinetobacter baumannii as a potential therapeutic approach

  2022cites this paper
• A bioinformatics approach to introduce novel multi-epitope vaccines against Acinetobacter baumannii retrieved from immunogenic extracellular loops of outer membrane proteins

  2022cites this paper
• Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance

  2022cites this paper
• Therapeutic strategies against potential antibiofilm targets of multidrug‐resistant Acinetobacter baumannii

  2022cites this paper
• Investigation of preformed design Acinetobacter Baumannii outer membrane protein A peptide vaccine candidate in reaction with serum antibodies from ICU staffs members

  2021cites this paper
• Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection

  2021cites this paper
• Where are we and how far is there to go in the development of an Acinetobacter vaccine?

  2021cites this paper
• A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against Acinetobacter baumannii Infection

  2021cites this paper
• The Role of Vaccines in Combating Antimicrobial Resistance

  2021cites this paper
• Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development

  2021cites this paper
• The combination of CipA and PBP-7/8 proteins contribute to the survival of C57BL/6 mice from sepsis of Acinetobacter baumannii.

  2021cites this paper
• Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It

  2021cites this paper
• Synthetic Pseudaminic-Acid-Based Antibacterial Vaccine Confers Effective Protection against Acinetobacter baumannii Infection

  2021cites this paper
• The impact of human vaccines on bacterial antimicrobial resistance. A review

  2021cites this paper
• Antibiotic Resistance Mechanisms and Their Transmission in Acinetobacter baumannii.

  2021cites this paper
• Evaluation the Reactivity of a Peptide-Based Monoclonal Antibody with Drug Resistant Pulsotypes of Acinetobacter Baumannii as Potential Therapeutic Approach

  2021cites this paper
• Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection

  2020cites this paper
• The current state of immunization against Gram-negative bacteria in children: a review of the literature

  2020cites this paper
• A Multi-epitope Peptide rOmp22 Encapsulated in Chitosan-PLGA Nanoparticles as Vaccine Candidate Against Acinetobacter baumannii Infection

  2020cites this paper
• PURIFICATION, CHARACTERIZATION AND EXPRESSION, OF RECOMBINANT OUTER MEMBRANE PROTEIN A (OMP A) OF ACINETOBACTER BAUMANNII LI311

  2020cites this paper
• Host Innate Immune Responses to Acinetobacter baumannii Infection

  2020cites this paper
• Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections

  2020cites this paper
• Outer Membrane Protein, Oma87 Prevents Acinetobacter baumannii Infection

  2020cites this paper
• Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi‐epitope based vaccine discovery

  2019cites this paper
• In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.

  2019cites this paper
• DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection

  2019cites this paper
• Top-Down Characterization of Lipooligosaccharides from Antibiotic-Resistant Bacteria.

  2019cites this paper
• Design and evaluation of a multi-epitope assembly peptide vaccine against Acinetobacter baumannii infection in mice.

  2019cites this paper
• MF59 adjuvant enhances the immunogenicity and protective immunity of the OmpK/Omp22 fusion protein from Acineterbacter baumannii through intratracheal inoculation in mice

  2019cites this paper
• Antibiotic Characterization of Acinetobacter baumannii Isolated from Clinical Samples and Production of Recombinant OmpA from Resistant Strains

  2018cites this paper
• Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice.

  2018cites this paper
• Potential targets for next generation antimicrobial glycoconjugate vaccines

  2018cites this paper
• Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii: An innovative approach.

  2018influential citation
• Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model

  2018cites this paper
• The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections

  2017cites this paper
• Mouse Models of Acinetobacter baumannii Infection

  2017cites this paper
• In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A.

  2017cites this paper
• Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology

  2017cites this paper
• Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets

  2016cites this paper
• Vaccines for Healthcare-associated Infections: Promise and Challenge.

  2016cites this paper
• Development of immunization trials against Acinetobacter baumannii

  2016cites this paper